Silo Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2011
Net Income	-3.7	-3.91	2.5	-3.11	-1.01	Upgrade
Share-Based Compensation	0.01	0.16	0.08	1.19	0.18	Upgrade
Other Operating Activities	0.46	0.25	-6.27	0.69	0.04	Upgrade
Operating Cash Flow	-3.22	-3.5	-2.28	-1.16	-0.79	Upgrade
Change in Investments	-4.15	0.09	7.19	0.04	0.19	Upgrade
Investing Cash Flow	-4.15	0.09	7.19	0.04	0.19	Upgrade
Share Issuance / Repurchase	-0.47	4.94	0	2.12	0	Upgrade
Debt Issued / Paid	0	0	0	0.02	0.27	Upgrade
Other Financing Activities	-	-	3.79	-	0.11	Upgrade
Financing Cash Flow	-0.47	4.94	3.79	2.13	0.38	Upgrade
Net Cash Flow	-7.84	1.53	8.71	1.02	-0.22	Upgrade
Free Cash Flow	-3.22	-3.5	-2.28	-1.16	-0.79	Upgrade
Free Cash Flow Margin	-4472.13%	-4850.94%	-3196.59%	-	-1957.96%	Upgrade
Free Cash Flow Per Share	-1.05	-1.53	-1.20	-0.88	-1.69	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).